MedTrace Logo

Ephedrine for Reducing Onset Time of Rocurinium in Elderly Patients

NCT06681662 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-01-17

No results posted yet for this study

Summary

The aim of this study is to determine the onset time of rocuronium after administration of ephedrine 0.15 mg/kg in patients with age ≥ 80 years. The hypothesis of this study is that ephedrine 0.15 mg/kg provides a shorter onset time compared to placebo (saline).

Conditions

  • Neuromuscular Blockade

Interventions

DRUG

Ephedrine Hydrochloride 30 mg/ml

0.15 mg/kg during induction.

DRUG

Saline (NaCl 0,9 %) (placebo)

1 ml during induction.

Sponsors & Collaborators

  • Matias Vested

    lead OTHER

Principal Investigators

  • Matias Vested · Rigshospitalet, University of Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-13
Primary Completion
2025-09-30
Completion
2025-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06681662 on ClinicalTrials.gov